Jamie Durchin
Medical · Lakeland, FLNPI 1649354812
Payments from drug & device makers
Across 971 payments — averaging $71.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$39K
- Otsuka America Pharmaceutical, Inc.$19K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$1K
- Supernus Pharmaceuticals, Inc.$872
- Takeda Pharmaceuticals U.S.A., Inc.$767
- plus $7K from 30 others
What the payments were for
- Speaking & faculty fees$49,52971%
- Travel & lodging$3,3615%
- Food & beverage$16,35724%
- Education$830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 232 | $39,314 |
| Otsuka America Pharmaceutical, Inc. | 121 | $19,102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 78 | $1,473 |
| Alkermes, Inc. | 55 | $1,224 |
| Supernus Pharmaceuticals, Inc. | 93 | $872 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $767 |
| Lundbeck LLC | 33 | $644 |
| Axsome Therapeutics, Inc. | 22 | $616 |
| Corium, LLC | 28 | $549 |
| Neurocrine Biosciences, Inc. | 27 | $463 |
| Tris Pharma Inc | 58 | $461 |
| Noven Therapeutics, LLC | 25 | $447 |
| Teva Pharmaceuticals USA, Inc. | 16 | $321 |
| Validus Pharmaceuticals LLC | 5 | $305 |
| Johnson & Johnson | 12 | $300 |
| Almatica Pharma LLC | 15 | $265 |
| Bausch Health US, LLC | 13 | $249 |
| E.r. Squibb & Sons, L.L.C. | 4 | $231 |
| Neos Therapeutics, LP | 13 | $230 |
| Avanir Pharmaceuticals, Inc. | 9 | $179 |
| Idorsia Pharmaceuticals US Inc | 9 | $164 |
| Ironshore Pharmaceuticals Inc. | 7 | $148 |
| Tempus AI, Inc | 9 | $142 |
| Vanda Pharmaceuticals Inc. | 6 | $139 |
| Indivior Inc. | 6 | $127 |
| Biogen | 2 | $125 |
| Eisai Inc. | 6 | $115 |
| Blue Earth Diagnostics | 3 | $93 |
| Sunovion Pharmaceuticals Inc. | 5 | $90 |
| Merck | 2 | $35 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Braeburn Inc. | 1 | $28 |
| Neuronetics, Inc. | 1 | $27 |
| Amgen | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$69,330 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 35 | $57,288 |
| TrintellixVortioxetine Hydrobromide | 25 | $25,593 |
| FanaptIloperidone | 11 | $23,005 |
| RexultiBrexpiprazole | 16 | $22,130 |
| Lurasidone Hcl | 21 | $5,447 |
| Ziprasidone Hcl | 19 | $2,963 |
| Aripiprazole | 35 | $2,849 |
| Vilazodone Hcl | 21 | $2,638 |
| Alprazolam | 272 | $1,623 |
| Duloxetine Hcl | 55 | $1,370 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $1,183 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $1,133 |
| Bupropion XlBupropion Hcl | 38 | $1,006 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $977 |
| Buspirone Hcl | 52 | $915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $39,314 | $57,28835 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $767 | $25,59325 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $139 | $23,00511 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $19,102 | $22,13016 claims |
| Almatica Pharma LLCSertraline Hcl | $265 | $15114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Lakeland
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.